Literature DB >> 3794399

The plaque-neutralization test as a measure of prior exposure to measles virus.

W A Orenstein, P Albrecht, K L Herrmann, R Bernier, K J Bart, E Z Rovira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3794399     DOI： 10.1093/infdis/155.1.146

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Determination of immune status to measles, rubella, and varicella-zoster viruses among medical students: assessment of historical information.

Authors:  D L Murray; M A Lynch
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

3.  A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Megan O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2011-05-01       Impact factor: 3.641

4.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Passive hemagglutination test for measles immunity and serodiagnosis.

Authors:  H Sakata; A Sugiura
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

6.  Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays.

Authors:  K B Hummel; D D Erdman; J Heath; W J Bellini
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

7.  Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV).

Authors:  Shixia Wang; Pavlo Sakhatskyy; Te-Hui W Chou; Shan Lu
Journal:  J Immunol Methods       Date:  2005-04-25       Impact factor: 2.303
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.